Keywords: shire, matthey, codevelopment, kidney, drug, pharmaceuticals, johnson

Shire and J Matthey codevelopment of kidney drug

Article | 26 June 1995

Print This

- Shire Pharmaceuticals and Johnson Matthey are to codevelop a new phosphate-binding agent for use in patients with kidney disease. Shire ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in